In a clinical study involving DMD patients5, we observed a decrease in inflammatory markers such as IL-6 and TGF-β, alongside functional improvements in muscle strength and plasma dystrophin levels. This evidence concerns the gene TGFB1 and Duchenne muscular dystrophy.